TECHNOLOGY
SCARLESS WOUND HEALING- GLOBAL UNMET NEED
I'm a paragraph. Click here to add your own text and edit me. It's easy.
THE PROBLEM
COVID-19: Multi-urgan injuries may cause scarring / fibrosis in
Lungs, heart, kidneys and liver
"Hypertrophic" dermal scars after surgery & burns can be a stigma,
a burden or even a physical handicap
with reduced mobility of joints.
Severe or unattractive dermal scars are also reported
after surgery in up to one third of Caucasians and
two thirds of Chinese and Polynesians.
Other potential indications:
Scarring and adhesions in body cavities after
-
hip or knee replacement
-
back surgery (spinal laminctomy)
-
abdominal surgery
-
gynecological surgery
OUR INNOVATION
Cellastra is pioneering two potentially revolutionary treatments:
VIRLEXA - inhaled after respiratory infections such as COVID-19 , &
SCARLEXA - applied under the skin or intra muscular after surgery.
These encoded gene vectors deliver the genetic code to the wound area
-
to enable robust production of an antiscarring peptide for several weeks
-
to promote scar less wound healing.